AbstractViral Hepatitis and Liver DiseaseToward Hepatitis B and hepatitis D elimination in CubaView Abstract
AbstractViral Hepatitis and Liver DiseaseOccult Hepatitis B Virus Infection among HIV negative and positive isolated anti-HBc individuals in Eastern EthiopiaView Abstract
AbstractViral Hepatitis and Liver DiseaseHealthcare consumption in addicted versus non-addicted hepatitis B and C patients in the NetherlandsView Abstract
AbstractViral Hepatitis and Liver DiseaseSeroprevalence and associated risk factors for Hepatitis B virus infection among barbers and their clients in two cities of CameroonView Abstract
AbstractViral Hepatitis and Liver DiseaseChallenge and Opportunity for HCV Elimination among Young PWID in New York City: Relatively Low RNA seroconversion and genetically linked HCV infectionsView Abstract
AbstractViral Hepatitis and Liver DiseaseCost Effectiveness of expanding treatment with Direct Acting Antiviral treatment to reduce Hepatitis C incidence among HIV infected MSM in ThailandView Abstract
AbstractViral Hepatitis and Liver DiseaseMissed Opportunities for HCV Elimination in Provincial Correctional Institutions in Ontario, CanadaView Abstract
AbstractViral Hepatitis and Liver DiseaseReduction of hepatitis C burden in Islamabad, Pakistan slums through CHW screen and treat programsView Abstract
AbstractViral Hepatitis and Liver DiseaseHCV elimination in France. The countdown has startedView Abstract
AbstractViral Hepatitis and Liver DiseaseModels of Care: Strategies towards Elimination of Hepatitis C in IcelandView Abstract
AbstractViral Hepatitis and Liver DiseaseThe TREAT-B score predicts disease progression in Ethiopian patients with chronic hepatitis BView Abstract
AbstractViral Hepatitis and Liver DiseaseExpression of HBV-infection markers in placenta of women with chronic hepatitis BView Abstract
AbstractViral Hepatitis and Liver DiseaseEliminating hepatitis B virus infection in west African migrants living in Barcelona: a community-based testing and vaccination model of care to link patients to liver specialistsView Abstract
AbstractViral Hepatitis and Liver DiseaseEnabling HCV scale up through the introduction of a simplified testing approach in Delhi: The HEAD-Start projectView Abstract
AbstractViral Hepatitis and Liver DiseaseChanges in hepatic fibrosis stages after achieving SVR following direct acting antiviral treatment in children with chronic hepatitis CView Abstract
AbstractViral Hepatitis and Liver DiseaseExternal validation of GES score to predict HCC risk in patients with HCV associated significant hepatic fibrosis following DAAs in genotype 1 and 2 in Japan.View Abstract
AbstractViral Hepatitis and Liver DiseaseDecentralized testing and treatment of hepatitis C in people who inject drugs– the Shared Addiction Care Copenhagen (SACC) projectView Abstract
AbstractViral Hepatitis and Liver DiseaseA novel hepatitis C intervention in Denmark to test and treat people who inject drugsView Abstract
AbstractViral Hepatitis and Liver DiseaseCollocating Hepatitis C Care at Syringe Exchange Programs: Hepatitis C treatment with Less Stigma.View Abstract
AbstractViral Hepatitis and Liver DiseaseRe-linkage to care: a novel strategy to achieve hepatitis C elimination in a University HospitalView Abstract
AbstractViral Hepatitis and Liver DiseaseRecall of HCV patients lost to follow-up. ReLinK study in two expert centres in FranceView Abstract
AbstractViral Hepatitis and Liver DiseaseA successful hepatitis C outreach service in a medically supervised injecting room: increased uptake of screening and high rates of treatment initiationView Abstract
AbstractViral Hepatitis and Liver DiseaseDual Sofosbuvir/Daclatasvir Therapy for Chronic Hepatitis C Infection: Lessons from Our Studies in Pediatric Age GroupsView Abstract
AbstractViral Hepatitis and Liver DiseaseProgress towards achieving hepatitis C elimination in the country of Georgia, April 2015 – June 2020View Abstract
AbstractViral Hepatitis and Liver DiseaseA Novel Approach Continuum from Identification to Elimination in HCV-Infected Individuals on Opioid Substitution Therapy and High-Risk PopulationsView Abstract
AbstractViral Hepatitis and Liver DiseaseRisks factors associated with HIV and hepatitis C virus co-infection among people who inject drugs in CambodiaView Abstract
AbstractViral Hepatitis and Liver DiseaseA Model for Collaborative Care to Increase Testing and Treatment of HCV in a Shelter Population During COVID-19View Abstract
AbstractViral Hepatitis and Liver DiseaseConcordance between FibroScan® and Aspartate aminotransferase-to-Platelet Ratio Index (APRI) using different cut-off values in 301 Asian adults with chronic HCV with no or compensated cirrhosis in Thailand and MalaysiaView Abstract
AbstractViral Hepatitis and Liver DiseaseStrategies for population-based screening and treatment of hepatitis B in sub-Saharan Africa: a mathematical modelling study in The GambiaView Abstract
AbstractViral Hepatitis and Liver DiseaseSustained reduction in prevalence of Hepatitis C viremina in the prison setting after 3rd year of TraPHepC (Treatment as prevention for hepatitis C) program in IcelandView Abstract
AbstractViral Hepatitis and Liver DiseaseThe Effect of COVID-19 on the Hepatitis C Screening in GeorgiaView Abstract
AbstractViral Hepatitis and Liver DiseaseReducing Read Time of Point of Care Test Preserves Detection of Hepatitis C Virus and Reduces Need for Reflex RNAView Abstract
AbstractViral Hepatitis and Liver DiseaseFrequency of Occult Hepatitis B Virus among blood Donors in Khartoum State, Sudan: a preliminary study.View Abstract
AbstractViral Hepatitis and Liver DiseaseA novel point -of- care test (POC) for diagnosis of hepatitis Core antigenView Abstract
AbstractViral Hepatitis and Liver DiseaseValidation of a novel point-of-care ALT test to determine treatment eligibility in hepatitis B patients: a pilot cohort studyView Abstract
AbstractViral Hepatitis and Liver DiseaseHepatitis C Epidemic and Barriers to Testing among MSM with High Risk Behaviors in China: A GSN-delivered Cross-sectional StudyView Abstract
AbstractViral Hepatitis and Liver DiseaseDrug resistance of hepatitis C virus to NS5A protein inhibitors in BelarusView Abstract
AbstractViral Hepatitis and Liver DiseaseSeroprevalence of Hepatitis B and C Among HIV-infected Children and Adolescents Receiving Antiretroviral Therapy in Anambra State, NigeriaView Abstract
AbstractViral Hepatitis and Liver DiseaseDetection of Viral Hepatitis and Linking to the Health Care of Trans People - InCide Project ContributionsView Abstract
AbstractViral Hepatitis and Liver DiseaseExpression of HBeAg, HBsAg, anti- HBe and anti-HCV in individuals with elevated IL-10View Abstract
AbstractViral Hepatitis and Liver DiseasePrevalence of Hepatitis B among Prisoners at Winneba Male and Nsawam Female Prison in GhanaView Abstract
AbstractViral Hepatitis and Liver DiseaseImmune Response to Hepatitis B Vaccine Following Complete Immunization of Children Attending Two Regional Hospitals in the Southwest Region of Cameroon: A Cross Sectional StudyView Abstract
AbstractViral Hepatitis and Liver DiseaseResults from two phase-3 double-blind, randomized, controlled trials, PROTECT and CONSTANT, evaluating immunogenicity and safety of the 3-antigen hepatitis B vaccine, Sci-B-Vac®, compared to the single-antigen vaccine, Engerix ® in adultsView Abstract
AbstractViral Hepatitis and Liver DiseaseEvaluation of hepatitis B vaccine efficacy among healthcare worker at Laquintinie Hospital, Douala, Cameroon.View Abstract
AbstractViral Hepatitis and Liver DiseaseResults of A Hepatitis C (HCV) Re-Engagement Strategy For Vulnerable PopulationsView Abstract
AbstractViral Hepatitis and Liver DiseaseHep Free 2030: Planning for Hepatitis Elimination in Hawai`i as Nimble, Collaborative PracticeView Abstract
AbstractViral Hepatitis and Liver DiseaseLedipasvir 90 mg/ Sofosbuvir 400 mg for treatment of Chronic Hepatitis C genotype 4 adolescents: Towards elimination of hepatitis in childrenView Abstract
AbstractViral Hepatitis and Liver DiseaseContact tracing to engage hard to reach injection networks and achieve micro-elimination: description of the ‘source patient indentification and group overlap treatment’ (spigot) pilot programView Abstract
AbstractViral Hepatitis and Liver DiseaseGilead Sciences’ Commitment to Global Elimination of Hepatitis C VirusView Abstract
AbstractViral Hepatitis and Liver DiseaseGlobal elimination of hepatitis C: meeting the World Health Organization’s 2030 goalView Abstract
AbstractViral Hepatitis and Liver DiseaseShort Chain Fatty Acids Delay the Pathogenesis of Hepatitis B Virus-Associated Hepatocellular Carcinoma in an HBx transgenic mouse modelView Abstract
AbstractViral Hepatitis and Liver DiseaseComparative analysis of hepatitis B virus serologic profiles and biochemical markers with viral loads in Ondo, Nigeria.View Abstract
AbstractViral Hepatitis and Liver DiseaseViral hepatitis B and C seroprevalence among at risk population in Taraba state: a seroprevalence studyView Abstract
AbstractViral Hepatitis and Liver DiseaseSeroprevalence of viral hepatitis among health care workers (HCWS) in Taraba state, NigeriaView Abstract
AbstractViral Hepatitis and Liver DiseaseSeroprevalence of hepatitis B surface antigen (HBsAG) and hepatitis C antibodies (HCVAb) among hemodialysis patients at the Yaounde General Hospital, Cameroon.View Abstract
AbstractViral Hepatitis and Liver DiseaseHigh seroprevalence of viral hepatitis among animal handlers in Abeokuta, NigeriaView Abstract
AbstractViral Hepatitis and Liver DiseaseSustainability of immune response to hepatitis B virus vaccination three years after vaccination among HIV-1 infected and uninfected adults in KenyaView Abstract
AbstractViral Hepatitis and Liver DiseaseAchieving sustained viral response (SVR) – is it a motivator for longterm positive lifestyle changes among people affected by VHC?View Abstract
AbstractViral Hepatitis and Liver DiseaseCo-located treatment verus co-located care coordination to engage people who inject drugs in HCV care at a syringe service program: preliminary results from the accessible care randomized clinical trialView Abstract
AbstractViral Hepatitis and Liver DiseaseSimplified HCV treatment model in primary healthcare in the country of GeorgiaView Abstract
AbstractViral Hepatitis and Liver DiseaseDepist’c pharma an innovative outreach HCV screening project in pharmacy for drugs users and general populationView Abstract
